Example: air traffic controller

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 …

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 1 June 7, 2021 ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LISTThis file is intended as a reference file for ICD-O-3 only and is not to be used for casefinding purposes. The ICD-O-3 site/typevalidation program was modified to allow only for the SITE/HISTOLOGY /behavior combinations listed in this publication. All other casesmust be any comments or questions about this document to:Ask A SEER SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 2 LIP C000-C006,C008-C009 NEOPLASM8008000/3 Neoplasm, malignant8001/3 Tumor cells, malignant8002/3 Malignant tumor, small cell type8003/3 Malignant tumor, giant cell type8004/3 Malignant tumor, spindle cell type8005/3 Malignant tumor, clear cell typeCARCINOMA, NOS8018010/2 Carcinoma in situ, NOS8010/3 Carcinoma, NOS8011/3 Epithelioma, malignant8012/3 Large cell carcinoma, NOS8013/3 Large cell neuroendocrine carcinoma8014/3 Large cell carcinoma w

Jun 07, 2021 · 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumor IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3 PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

Tags:

  9575

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 …

1 ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 1 June 7, 2021 ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LISTThis file is intended as a reference file for ICD-O-3 only and is not to be used for casefinding purposes. The ICD-O-3 site/typevalidation program was modified to allow only for the SITE/HISTOLOGY /behavior combinations listed in this publication. All other casesmust be any comments or questions about this document to:Ask A SEER SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 2 LIP C000-C006,C008-C009 NEOPLASM8008000/3 Neoplasm, malignant8001/3 Tumor cells, malignant8002/3 Malignant tumor, small cell type8003/3 Malignant tumor, giant cell type8004/3 Malignant tumor, spindle cell type8005/3 Malignant tumor, clear cell typeCARCINOMA, NOS8018010/2 Carcinoma in situ, NOS8010/3 Carcinoma, NOS8011/3 Epithelioma, malignant8012/3 Large cell carcinoma, NOS8013/3 Large cell neuroendocrine carcinoma8014/3 Large cell carcinoma with rhabdoid phenotype8015/3 Glassy cell carcinomaCARCINOMA, UNDIFF.

2 , NOS8028020/3 Carcinoma, undifferentiated type, NOS8021/3 Carcinoma, anaplastic type, NOS8022/3 Pleomorphic carcinomaGIANT & SPINDLE CELL CARCINOMA8038030/3 Giant cell and spindle cell carcinoma8031/3 Giant cell carcinoma8032/3 Spindle cell carcinoma8033/3 Pseudosarcomatous carcinoma8034/3 Polygonal cell carcinoma8035/3 Carcinoma with osteoclast-like giant cellsPAPILLARY CARCINOMA, NOS8058050/2 Papillary carcinoma in situ8050/3 Papillary carcinoma, NOS8051/3 Verrucous carcinoma, NOS8052/2 Papillary squamous cell carcinoma, non-invasive8052/3 Papillary squamous cell carcinomaSQUAMOUS CELL CARCINOMA, NOS8078070/2 Squamous cell carcinoma in situ, NOS8070/3 Squamous cell carcinoma, NOS8071/3Sq. cell carcinoma, keratinizing, NOS8072/3Sq. cell carcinoma, lg.

3 Cell, cell carcinoma, sm. cell, cell carcinoma, spindle cell8075/3 Squamous cell carcinoma, adenoid8076/2Sq. cell carc. in situ with question. stromal cell carcinoma, micro-invasive8078/3 Squamous cell carcinoma with horn formationICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 3 LIP C000-C006,C008-C009 LYMPHOEPITHELIAL CARCINOMA8088081/2 Bowen disease8082/3 Lymphoepithelial carcinoma8083/3 Basaloid squamous cell carcinoma8084/3 Squamous cell carcinoma, clear cell typeADENOCARCINOMA, NOS8148140/2 Adenocarcinoma in situ8140/3 Adenocarcinoma, NOS8141/3 Scirrhous adenocarcinoma8143/3 Superficial spreading adenocarcinoma8147/3 Basal cell adenocarcinomaADENOID CYSTIC & CRIBRIFORM cystic carcinoma8201/2 Cribriform carcinoma in situ8201/3 Cribriform carcinomaBRONCHIOLO-ALVEOLAR with mixed subtypesPAPILLARY ADENOCARCINOMA, NOS8268260/3 Papillary adenocarcinoma.

4 NOS8261/2 Adenocarcinoma in situ in villous adenoma8261/3 Adenocarcinoma in villous adenoma8262/3 Villous adenocarcinoma8263/2 Adenocarcinoma in situ in tubulovillous adenoma8263/3 Adenocarcinoma in tubulovillous adenomaMUCOEPIDERMOID CARCINOMA8438430/3 Mucoepidermoid carcinomaMUCINOUS ADENOCARCINOMA8488480/3 Mucinous adenocarcinoma8481/3 Mucin-producing adenocarcinomaNEVI & MELANOMAS8728720/2 Melanoma in situ8720/3 Malignant melanoma, NOS8721/3 Nodular melanoma8722/3 Balloon cell melanoma8723/3 Malignant melanoma, regressingAMELANOTIC MELANOMA8738730/3 Amelanotic melanomaMAL. MEL. IN JUNCT. NEVUS8748743/3 Superficial spreading melanoma8745/3 Desmoplastic melanoma, malignant8746/3 Mucosal lentiginous melanomaEPITHELIOID CELL MELANOMA8778770/3 Mixed epithel.

5 & spindle cell melanoma8771/3 Epithelioid cell melanoma8772/3 Spindle cell melanoma, NOSICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 4 LIP C000-C006,C008-C009 MIXED TUMOR, MALIGNANT, NOS8948940/3 Mixed tumor, malignant, NOS8941/3 Carcinoma in pleomorphic adenomaKAPOSI SARCOMA9149140/3 Kaposi sarcomaFOLLIC. & MARGINAL LYMPH, NOS9699699/3 Marginal zone B-cell lymphoma, NOSLYMPHOID LEUKEMIA, NOS9829823/3 Chronic lymphocytic leukemia/small lymphocytic lymphomaICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 5 BASEOFTONGUE C019 NEOPLASM8008000/3 Neoplasm, malignant8001/3 Tumor cells, malignant8002/3 Malignant tumor, small cell type8003/3 Malignant tumor, giant cell type8004/3 Malignant tumor, spindle cell type8005/3 Malignant tumor, clear cell typeCARCINOMA, NOS8018010/2 Carcinoma in situ, NOS8010/3 Carcinoma, NOS8011/3 Epithelioma, malignant8012/3 Large cell carcinoma.

6 NOS8013/3 Large cell neuroendocrine carcinoma8014/3 Large cell carcinoma with rhabdoid phenotype8015/3 Glassy cell carcinomaCARCINOMA, UNDIFF., NOS8028020/3 Carcinoma, undifferentiated type, NOS8021/3 Carcinoma, anaplastic type, NOS8022/3 Pleomorphic carcinomaGIANT & SPINDLE CELL CARCINOMA8038030/3 Giant cell and spindle cell carcinoma8031/3 Giant cell carcinoma8032/3 Spindle cell carcinoma8033/3 Pseudosarcomatous carcinoma8034/3 Polygonal cell carcinoma8035/3 Carcinoma with osteoclast-like giant cellsPAPILLARY CARCINOMA, NOS8058050/2 Papillary carcinoma in situ8050/3 Papillary carcinoma, NOS8051/3 Verrucous carcinoma, NOS8052/2 Papillary squamous cell carcinoma, non-invasive8052/3 Papillary squamous cell carcinomaSQUAMOUS CELL CARCINOMA, NOS8078070/2 Squamous cell carcinoma in situ, NOS8070/3 Squamous cell carcinoma, NOS8071/3Sq.

7 Cell carcinoma, keratinizing, NOS8072/3Sq. cell carcinoma, lg. cell, cell carcinoma, sm. cell, cell carcinoma, spindle cell8075/3 Squamous cell carcinoma, adenoid8076/2Sq. cell carc. in situ with question. stromal cell carcinoma, micro-invasive8078/3 Squamous cell carcinoma with horn formationICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 6 BASEOFTONGUE C019 LYMPHOEPITHELIAL CARCINOMA8088081/2 Bowen disease8082/3 Lymphoepithelial carcinoma8083/3 Basaloid squamous cell carcinoma8084/3 Squamous cell carcinoma, clear cell type8085/3 Squamous cell carcinoma, HPV-positive8086/3 Squamous cell carcinoma, HPV-negativeADENOCARCINOMA, NOS8148140/2 Adenocarcinoma in situ8140/3 Adenocarcinoma.

8 NOS8141/3 Scirrhous adenocarcinoma8143/3 Superficial spreading adenocarcinoma8147/3 Basal cell adenocarcinomaADENOID CYSTIC & CRIBRIFORM cystic carcinoma8201/2 Cribriform carcinoma in situ8201/3 Cribriform carcinomaBRONCHIOLO-ALVEOLAR with mixed subtypesMUCOEPIDERMOID CARCINOMA8438430/3 Mucoepidermoid carcinomaMUCINOUS ADENOCARCINOMA8488480/3 Mucinous adenocarcinoma8481/3 Mucin-producing adenocarcinomaADENOSQUAMOUS CARCINOMA8568560/3 Adenosquamous carcinoma8562/3 Epithelial-myoepithelial carcinomaADENOCA. WITH METAPLASIA8578570/3 Adenocarcinoma with squamous metaplasia8571/3 Adenocarcinoma w cartilag. & oss. with spindle cell mataplasia8573/3 Adenocarcinoma with apocrine metaplasia8574/3 Adenocarcinoma with neuroendocrine carcinoma, NOSNEVI & MELANOMAS8728720/2 Melanoma in situ8720/3 Malignant melanoma, NOS8721/3 Nodular melanoma8722/3 Balloon cell melanoma8723/3 Malignant melanoma, regressingSARCOMA, NOS8828825/3 Myofibroblastic sarcomaRHABDOMYOSARCOMA, NOS8908900/3 Rhabdomyosarcoma, NOS8901/3 Pleomorphic rhabdomyosarcoma, adult type8902/3 Mixed type rhabdomyosarcomaICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 7 BASEOFTONGUE C019 EMBRYONAL RHABDOMYOSARCOMA8918910/3 Embryonal rhabdomyosarcoma8912/3 Spindle cell rhabdomyosarcomaMIXED TUMOR.

9 MALIGNANT, NOS8948940/3 Mixed tumor, malignant, NOS8941/3 Carcinoma in pleomorphic adenomaKAPOSI SARCOMA9149140/3 Kaposi sarcomaMALIGNANT LYMPHOMA, NOS9599590/3 Malignant lymphoma, NOS9591/3 Malignant lymphoma, non-Hodgkin9596/3 Composite Hodgkin and non-Hodgkin lymphomaHODGKIN LYMPHOMA9659650/3 Hodgkin lymphoma, NOS9651/3 Hodgkin lymphoma, lymphocyte-rich9652/3 Hodgkin lymphoma, mixed cellularity, NOS9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular9659/3 Hodgkin lymph., nodular lymphocyte LYMPHOMA, NOD. granuloma [obs]9662/3 Hodgkin sarcoma [obs]9663/3 Hodgkin lymphoma, nodular sclerosis, NOS9664/3 Hodgkin lymphoma, nod. scler., cellular phase9665/3 Hodgkin lymphoma, nod.

10 Scler., grade 19667/3 Hodgkin lymphoma, nod. scler., grade 2ML, SMALL B-CELL LYMPHOCYTIC9679670/3ML, small B lymphocytic, NOS9671/3ML, lymphoplasmacytic9673/3 Mantle cell lymphoma9675/3ML, mixed sm. and lg. cell, diffuseML, LARGE B-CELL, DIFFUSE9689680/3ML, large B-cell, diffuse9684/3ML, large B-cell, diffuse, immunoblastic, NOS9687/3 Burkitt lymphoma, NOS9688/3T-cell histiocyte rich large B-cell lymphomaFOLLIC. & MARGINAL LYMPH, NOS9699690/3 Follicular lymphoma, NOS9691/3 Follicular lymphoma, grade 29695/3 Follicular lymphoma, grade 19698/3 Follicular lymphoma, grade 39699/3 Marginal zone B-cell lymphoma, NOSICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST June 7, 2021 8 BASEOFTONGUE C019T-CELL LYMPHOMAS9709701/3 Sezary syndrome9702/3 Mature T-cell lymphoma, NOS9705/3 Angioimmunoblastic T-cell lymphomaOTHER SPEC.


Related search queries